<DOC>
	<DOCNO>NCT01665703</DOCNO>
	<brief_summary>This pilot study design evaluate imaging parameter indicative underlying tumor biology . Patients large renal mass ( &gt; 3 cm , discretion investigator ) planning undergo nephrectomy identify , recruit undergo contrast-enhanced magnetic resonance-Fluorodeoxyglucose-positron emission tomography ( MR-FDG-PET ) scan .</brief_summary>
	<brief_title>Imaging Correlates Renal Cell Carcinoma Biological Features</brief_title>
	<detailed_description>This pilot study design evaluate imaging parameter indicative underlying tumor biology . Patients large renal mass ( &gt; 3 cm , discretion investigator ) planning undergo nephrectomy identify , recruit undergo contrast-enhanced magnetic resonance-Fluorodeoxyglucose-positron emission tomography ( MR-FDG-PET ) scan . Samples collect tumor remove undergo variety laboratory test , include biomarker assessment genotyping . By examine primary renal mass via combination MR FDG-PET functional imaging concert tissue base test , area hypermetabolism hypervascularization evaluate feature HIF activation tumor subtype .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Deoxyglucose</mesh_term>
	<criteria>â‰¥ 18 year age ( upper age limit ) Informed consent obtain sign Clinically suspect RCC base imaging perform prior enrollment Planned nephrectomy schedule accommodate MRFDGPET scan within 4 week prior surgery Willing undergo gadolinium enhance MRI simultaneous acquisition FDGPET uptake tumor within 4 week prior nephrectomy Willing consent genetic proteomic analysis tumor germline nucleic acid Women childbearing potential must negative serum urine pregnancy test perform within 7 day prior FDGPETMRI Breast feed woman 24 hour FDG injection Patient willing fast 4 hour , include avoid sugarcontaining drink . Patient willing drink least 32 ounce water ( nosugarcontaining fluid ) within 4 hour prior arrive scan . History severe reaction gadoliniumenhanced MRI Poorly control diabetes mellitus Inability tolerate PET and/or MRI Presence pacemaker intracranial aneurysm clip GFR &lt; 30mL/min measured via CockcroftGault equation Inability lie flat &gt; 1 hour Pregnant female History prior malignancy within past 5 year exclude unless disease free 3 year unless completely resect nonmelanoma skin cancer , low risk prostate cancer , low risk tumor history discretion investigator . Substance abuse , medical , psychological , social condition may interfere patient 's participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>[ 18F ]</keyword>
	<keyword>Fluorodeoxyglucose Positron Emission Tomography-Magnetic Resonance Imaging</keyword>
	<keyword>FDG-PET-MRI</keyword>
	<keyword>Renal Cell Carcinoma</keyword>
	<keyword>Pilot Study</keyword>
	<keyword>LCCC 1213</keyword>
	<keyword>UNC Lineberger</keyword>
</DOC>